Body Mass Index and Albumin Level In Severe Preeclampsia Conservative Treatment Cases

Authors

  • Esmond Winarko RSUD Dr. Soetomo
  • Muhammad Yusuf Universitas Airlangga

Abstract

Background : Severe preeclampsia is an obstetrical problem and one of the leading cause of death in obstetric. Conservative treatment for severe preeclampsia is a complicated and risky choice, but still a considerable option to achieve a better fetal outcome. Many factors that influence the results of conservative management are complex and still very much controversial. Objective: To study the BMI and albumin level of severe preeclampsia patients who underwent conservative management in dr. Soetomo General Hospital obstetric ward in 2018 – 2019. Method: This is a descriptive cross sectional study, where the data are obtained from morning reports, obstetric ward registry and dr. Soetomo General Hospital medical record during 2018 – 2019. Results: The total conservative cases were 51 in 2018 and 69 in 2019. The majority of the patients were 20-34 years old, multigravida, non-booked cases, Javanese ethnicity, and addressed in Surabaya. Most of them were obese (with BMI ≥ 30 kg/m2) with similar BMI distribution in the successful and unsuccessful conservative management groups. Most of our patients had albumin level below 3,5 g/dl. The majority of the patients were terminated by caesarean section with the fetal outcome mostly weighed less than 2000 g. Conclusion: The majority of the patients treated conservatively were 20-34 years old, multigravida, non-booked cases, Javanese ethnicity, and addressed in Surabaya. Most of the patients have BMI ≥ 30 kg/m2 and albumin levels below 3,5.

Downloads

Download data is not yet available.

References

Brown MA, Buddle ML. Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features. Med J Aust 1996; 165: 360–365.

Chu J, Johnston TA, Geoghegan J; Royal College of Obstetricians and Gynaecologists. Maternal Collapse in Pregnancy and the Puerperium: Green-top Guideline No. 56. BJOG. 2020 Apr;127(5):e14-e52. doi: 10.1111/1471-0528.15995. Epub 2019 Dec 17. PMID: 31845507.

Dinas Kesehatan Provinsi Jawa Timur. Profil Kesehatan Provinsi Jawa Timur 2015. Surabaya: Dinas Kesehatan Provinsi Jawa Timur

Djannah, SN, Arianti IS. Gambaran Epidemiologi Kejadian Preeklampsia/ Eklampsia di RSU PKU Muhammadiyah Yogyakarta Tahun 2007-2009. Buletin Penelitian Sistem Kesehatan. 2010 Sept 3. 13(4) 378-385

Drife JO. Weight gain in pregnancy: eating for two or just getting Fat? Br Med J 1986; 293: 903–904.

Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiolgy. Cardiovasc J Afr. 2016 Mar-Apr;27(2):71-8. doi: 10.5830/CVJA-2016-009. PMID: 27213853; PMCID: PMC4928171.

George EM, Warrington JP, Spradley FT, Palei AC, Granger JP. The heme oxygenases: important regulators of pregnancy and preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2014 Oct 1;307(7):R769-77. doi: 10.1152/ajpregu.00132.2014. Epub 2014 Jun 4. PMID: 24898840; PMCID: PMC4187186.

Gojnic M, Petkovic S, Papic M et al. Plasma albumin level as an indicator of severity of preeclampsia. Clin Exp Obstet Gynecol 2004; 31: 209–210.

Jang HC, Cho NH, Min YK, Han IK, Jung KB, Metzger BE. Incrased macrosomia and perinatal morbidity independent of maternal obesity and advanced age in korean women with GDM. Diabetes Care 1997; 20: 1582–1588.

Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia Tahun 2017. 2018. Jakarta: Kementerian Kesehatan Republik Indonesia.

Ohkuchi A, Iwasaki R, Suzuki H, Hirashima C, Takahashi K, Usui R, et al. Normal and high-normal blood pressures, but not body mass index, are risk factors for the subsequent occurrence of both preeclampsia and gestational hypertension: a retrospective cohort study. Hypertens Res 2006; 29: 161–167.

Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011;2011:481095. doi: 10.1155/2011/481095. Epub 2011 Apr 4. PMID:21547090;PMCID: PMC308 7154.

Sibai, B., Dekker, G., & Kupferminc, M. Pre-eclampsia. The Lancet. 2005;365 (9461), 785–799. doi:10.1016/ s0140-6736(05)17987-2

Vahidrodsari F, Ayati S, Ayatollahi H, Shahabian M, Ismail H. [Comparison of serum ceruloplasmin levels in normal pregnancy and preeclampsia.] Journal of Medical Council of Islamic Republic of Iran 2009; 27: 437–442. (in Persian)

Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003;22(2):203-12. doi: 10.1081/PRG-120021066. PMID: 12909005.

Published

2020-09-01

How to Cite

Winarko, E., & Yusuf, M. (2020). Body Mass Index and Albumin Level In Severe Preeclampsia Conservative Treatment Cases. International Islamic Medical Journal, 1(2), 50-58. Retrieved from https://journal2.unusa.ac.id/index.php/IIMJ/article/view/1614

Issue

Section

Articles